Drug Type Recombinant protein |
Synonyms |
Mechanism CCL19 inhibitors(MIP 3 alpha ligand inhibitors), Chemokine receptors antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Preclinical | US | - |